Search research articles
Contact Us
Filters
Showing results (71-80 of 85) with videos related to
Page
of 9
Sort By:
Theranostics
|
July 1, 2024
Theranostic digital twins: Concept, framework and roadmap towards personalized radiopharmaceutical therapies
Hamid Abdollahi, Fereshteh Yousefirizi, Isaac Shiri, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 2, 2026
Pulling Together: A 5-Year Plan to Improve Theranostic Outcomes by Improving the Accuracy of Dosimetry-An FNIH Joint Academic, Clinical, and Industrial Collaboration
Dale L Bailey, John C Dickson, Suzanne E Lapi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 10, 2025
Recommendations for Standardizing Nuclear Medicine Terminology and Data in the Era of Theranostics and Artificial Intelligence
Tyler J Bradshaw, Julia Brosch-Lenz, Carlos Uribe, et al.
European Journal of Medicinal Chemistry
|
February 17, 2024
Development, preclinical evaluation and preliminary dosimetry profiling of SB03178, a first-of-its-kind benzo[h]quinoline-based fibroblast activation protein-α-targeted radiotheranostic for cancer imaging and therapy
Shreya Bendre, Helen Merkens, Hsiou-Ting Kuo, et al.
EJNMMI Physics
|
September 14, 2024
Quantitative SPECT imaging of <sup>155</sup>Tb and <sup>161</sup>Tb for preclinical theranostic radiopharmaceutical development
Helena Koniar, Scott McNeil, Luke Wharton, et al.
Bioconjugate Chemistry
|
April 23, 2019
Functionally Versatile and Highly Stable Chelator for <sup>111</sup>In and <sup>177</sup>Lu: Proof-of-Principle Prostate-Specific Membrane Antigen Targeting
Lily Li, María de Guadalupe Jaraquemada-Peláez, Hsiou-Ting Kuo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 13, 2025
Computational Nuclear Oncology Toward Precision Radiopharmaceutical Therapies: Current Tools, Techniques, and Uncharted Territories
Tahir Yusufaly, Emilie Roncali, Julia Brosch-Lenz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 22, 2025
Can <sup>177</sup>Lu-DOTATATE Kidney Absorbed Doses be Predicted from Pretherapy SSTR PET? Findings from Multicenter Data
Azadeh Akhavanallaf, Zhonglin Lu, Avery B Peterson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 23, 2025
Computational Nuclear Oncology Toward Precision Radiopharmaceutical Therapies: Ethical, Regulatory, and Socioeconomic Dimensions of Theranostic Digital Twins
Lidia Strigari, Jazmin Schwarz, Tyler Bradshaw, et al.
Journal of Endourology
|
March 1, 2005
Current trends in urologic laparoscopic surgery
Corollos S Abdelshehid, Louis Eichel, David Lee, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 85) with videos related to
Sort By:
Page
of 9
Theranostics
|
July 1, 2024
Theranostic digital twins: Concept, framework and roadmap towards personalized radiopharmaceutical therapies
Hamid Abdollahi, Fereshteh Yousefirizi, Isaac Shiri, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 2, 2026
Pulling Together: A 5-Year Plan to Improve Theranostic Outcomes by Improving the Accuracy of Dosimetry-An FNIH Joint Academic, Clinical, and Industrial Collaboration
Dale L Bailey, John C Dickson, Suzanne E Lapi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 10, 2025
Recommendations for Standardizing Nuclear Medicine Terminology and Data in the Era of Theranostics and Artificial Intelligence
Tyler J Bradshaw, Julia Brosch-Lenz, Carlos Uribe, et al.
European Journal of Medicinal Chemistry
|
February 17, 2024
Development, preclinical evaluation and preliminary dosimetry profiling of SB03178, a first-of-its-kind benzo[h]quinoline-based fibroblast activation protein-α-targeted radiotheranostic for cancer imaging and therapy
Shreya Bendre, Helen Merkens, Hsiou-Ting Kuo, et al.
EJNMMI Physics
|
September 14, 2024
Quantitative SPECT imaging of <sup>155</sup>Tb and <sup>161</sup>Tb for preclinical theranostic radiopharmaceutical development
Helena Koniar, Scott McNeil, Luke Wharton, et al.
Bioconjugate Chemistry
|
April 23, 2019
Functionally Versatile and Highly Stable Chelator for <sup>111</sup>In and <sup>177</sup>Lu: Proof-of-Principle Prostate-Specific Membrane Antigen Targeting
Lily Li, María de Guadalupe Jaraquemada-Peláez, Hsiou-Ting Kuo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 13, 2025
Computational Nuclear Oncology Toward Precision Radiopharmaceutical Therapies: Current Tools, Techniques, and Uncharted Territories
Tahir Yusufaly, Emilie Roncali, Julia Brosch-Lenz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 22, 2025
Can <sup>177</sup>Lu-DOTATATE Kidney Absorbed Doses be Predicted from Pretherapy SSTR PET? Findings from Multicenter Data
Azadeh Akhavanallaf, Zhonglin Lu, Avery B Peterson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 23, 2025
Computational Nuclear Oncology Toward Precision Radiopharmaceutical Therapies: Ethical, Regulatory, and Socioeconomic Dimensions of Theranostic Digital Twins
Lidia Strigari, Jazmin Schwarz, Tyler Bradshaw, et al.
Journal of Endourology
|
March 1, 2005
Current trends in urologic laparoscopic surgery
Corollos S Abdelshehid, Louis Eichel, David Lee, et al.
Page
of 9